These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31685313)

  • 1. The transcription factor Twist1 in the distal nephron but not in macrophages propagates aristolochic acid nephropathy.
    Ren J; Rudemiller NP; Wen Y; Lu X; Privratsky JR; Crowley SD
    Kidney Int; 2020 Jan; 97(1):119-129. PubMed ID: 31685313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twist1 in Infiltrating Macrophages Attenuates Kidney Fibrosis
    Ren J; Zhang J; Rudemiller NP; Griffiths R; Wen Y; Lu X; Privratsky JR; Gunn MD; Crowley SD
    J Am Soc Nephrol; 2019 Sep; 30(9):1674-1685. PubMed ID: 31315922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage interferon regulatory factor 4 deletion ameliorates aristolochic acid nephropathy via reduced migration and increased apoptosis.
    Sasaki K; Terker AS; Tang J; Cao S; Arroyo JP; Niu A; Wang S; Fan X; Zhang Y; Bennett SR; Zhang MZ; Harris RC
    JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35025763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration.
    Ren J; Xu Y; Lu X; Wang L; Ide S; Hall G; Souma T; Privratsky JR; Spurney RF; Crowley SD
    JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34369383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice.
    Urate S; Wakui H; Azushima K; Yamaji T; Suzuki T; Abe E; Tanaka S; Taguchi S; Tsukamoto S; Kinguchi S; Uneda K; Kanaoka T; Atobe Y; Funakoshi K; Yamashita A; Tamura K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renoprotective effect of
    Feng W; Ying WZ; Li X; Curtis LM; Sanders PW
    Am J Physiol Renal Physiol; 2021 Jan; 320(1):F87-F96. PubMed ID: 33283645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twist1 regulates macrophage plasticity to promote renal fibrosis through galectin-3.
    Wu Q; Sun S; Wei L; Liu M; Liu H; Liu T; Zhou Y; Jia Q; Wang D; Yang Z; Duan M; Yang X; Gao P; Ning X
    Cell Mol Life Sci; 2022 Feb; 79(3):137. PubMed ID: 35182235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of TFEB-mediated autophagy to tubulointerstitial fibrosis in mice with adenine-induced chronic kidney disease.
    Yuan H; Zheng C; Zhu L; Song Z; Dai L; Hu Q; Wang L; Chen Y; Xiong J
    Biomed Pharmacother; 2021 Jan; 133():110949. PubMed ID: 33227703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mononuclear phagocytes orchestrate prolyl hydroxylase inhibition-mediated renoprotection in chronic tubulointerstitial nephritis.
    Schley G; Klanke B; Kalucka J; Schatz V; Daniel C; Mayer M; Goppelt-Struebe M; Herrmann M; Thorsteinsdottir M; Palsson R; Beneke A; Katschinski DM; Burzlaff N; Eckardt KU; Weidemann A; Jantsch J; Willam C
    Kidney Int; 2019 Aug; 96(2):378-396. PubMed ID: 31146971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy.
    Baudoux TE; Pozdzik AA; Arlt VM; De Prez EG; Antoine MH; Quellard N; Goujon JM; Nortier JL
    Kidney Int; 2012 Nov; 82(10):1105-13. PubMed ID: 22854641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice.
    Dai XY; Huang XR; Zhou L; Zhang L; Fu P; Manthey C; Nikolic-Paterson DJ; Lan HY
    Oncotarget; 2016 Mar; 7(10):10841-56. PubMed ID: 26909597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-382 contributes to renal fibrosis secondary to aristolochic acid-induced kidney injury via PTEN signaling pathway.
    Wang X; Xue N; Zhao S; Shi Y; Ding X; Fang Y
    Cell Death Dis; 2020 Aug; 11(8):620. PubMed ID: 32796834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of relaxin in a mouse model of aristolochic acid nephropathy.
    Yang X; Thorngren D; Chen Q; Wang M; Xie X
    Biomed Pharmacother; 2019 Jul; 115():108917. PubMed ID: 31060002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment of model of aristolochic acid-induced chronic renal interstitial fibrosis in rats].
    Zheng F; Zhang X; Huang Q
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1095-100. PubMed ID: 11766605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy.
    Pozdzik AA; Salmon IJ; Husson CP; Decaestecker C; Rogier E; Bourgeade MF; Deschodt-Lanckman MM; Vanherweghem JL; Nortier JL
    Nephrol Dial Transplant; 2008 Aug; 23(8):2480-91. PubMed ID: 18385385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twist1 in T Lymphocytes Augments Kidney Fibrosis after Ureteral Obstruction.
    Ren J; Lu X; Griffiths R; Privratsky JR; Crowley SD
    Kidney360; 2021 May; 2(5):784-794. PubMed ID: 35373065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myofibroblasts acquire retinoic acid-producing ability during fibroblast-to-myofibroblast transition following kidney injury.
    Nakamura J; Sato Y; Kitai Y; Wajima S; Yamamoto S; Oguchi A; Yamada R; Kaneko K; Kondo M; Uchino E; Tsuchida J; Hirano K; Sharma K; Kohno K; Yanagita M
    Kidney Int; 2019 Mar; 95(3):526-539. PubMed ID: 30661714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP-7/Smads-induced inhibitor of differentiation 2 (Id2) upregulation and Id2/Twist interaction was involved in attenuating diabetic renal tubulointerstitial fibrosis.
    Xiao Y; Jiang X; Peng C; Zhang Y; Xiao Y; Liang D; Shi M; Wang Y; Zhang F; Guo B
    Int J Biochem Cell Biol; 2019 Nov; 116():105613. PubMed ID: 31539631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of mitochondrial injury in Caulis Aristolochia manshuriensis-induced chronic aristolochic acid nephropathy.
    Liu X; Wu J; Wang J; Fan J; Feng X; Yu X; Yang X
    Drug Chem Toxicol; 2017 Jan; 40(1):115-124. PubMed ID: 27250112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.
    Chen H; Cao G; Chen DQ; Wang M; Vaziri ND; Zhang ZH; Mao JR; Bai X; Zhao YY
    Redox Biol; 2016 Dec; 10():168-178. PubMed ID: 27750081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.